+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain



ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain



Molecular Neurodegeneration 4: 53



ZnT3 is a membrane Zn(2+ )transporter that is responsible for concentrating Zn(2+ )into neuronal presynaptic vesicles. Zn(2+ )homeostasis in the brain is relevant to Alzheimer's disease (AD) because Zn(2+ )released during neurotransmission may bind to Abeta peptides, accelerating the assembly of Abeta into oligomers which have been shown to impair synaptic function. We quantified ZnT3 mRNA levels in Braak-staged human post mortem (pm) brain tissue from medial temporal gyrus, superior occipital gyrus, superior parietal gyrus, superior frontal gyrus and cerebellum from individuals with AD (n = 28), and matched controls (n = 5) using quantitative real-time PCR. ZnT3 mRNA levels were significantly decreased in all four cortical regions examined in the AD patients, to 45-60% of control levels. This reduction was already apparent at Braak stage 4 in most cortical regions examined. Quantification of neuronal and glial-specific markers in the same samples (neuron-specific enolase, NSE; and glial fibrillary acidic protein, GFAP) indicated that loss of cortical ZnT3 expression was more pronounced, and occurred prior to, significant loss of NSE expression in the tissue. Significant increases in cortical GFAP expression were apparent as the disease progressed. No gene expression changes were observed in the cerebellum, which is relatively spared of AD neuropathology. This first study to quantify ZnT3 mRNA levels in human pm brain tissue from individuals with AD and controls has revealed a significant loss of ZnT3 expression in cortical regions, suggesting that neuronal cells in particular show reduced expression of ZnT3 mRNA in the disease. This suggests that altered neuronal Zn(2+ )handling may be an early event in AD pathogenesis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056979259

Download citation: RISBibTeXText

PMID: 20030848

DOI: 10.1186/1750-1326-4-53


Related references

α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. Brain Research 1459: 71-80, 2012

Oxidative Stress Levels in the Brain Are Determined by Post-Mortem Interval and Ante-Mortem Vitamin C State but Not Alzheimer's Disease Status. Nutrients 10(7):, 2018

N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue. Journal of the Neurological Sciences 127(2): 230-233, 1994

Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain. Neurobiology of Disease 74: 281-294, 2015

Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience 69(1): 125-138, 1995

Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sciences 26(20): 1683-1689, 1980

Post mortem levels of some brain peptidases in alzheimer's disease reduction in proline endopeptidase activity in cerebral cortex. Neuroscience Research Communications 9(2): 73-82, 1991

Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients. Neuroscience Letters 591: 19-24, 2015

Altered levels of G-alpha-s protein and mRNA levels in post-mortem brain tissue in bipolar affective disorder. Society for Neuroscience Abstracts 21(1-3): 1736, 1995

Inositol levels in post-mortem brain samples of Alzheimer's patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry 22(8): 1241-1250, 1998

Stability of brain Rna post mortem : effect of Alzheimer's disease. Biochemical Society Transactions 15(3): 558-559, 1987

Analysis of RNA from Alzheimer's Disease Post-mortem Brain Tissues. Molecular Neurobiology 53(2): 1322-1328, 2016

mRNA levels of BACE1 and its interacting proteins, RTN3 and PPIL2, correlate in human post mortem brain tissue. Neuroscience 274: 44-52, 2015

Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 30(8): 1548-1556, 2005

Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients. Current Aging Science 1(3): 175-181, 2008